Associated Papers
Identification of recurrent MYH7 variant hypertrophic cardiomyopathy patients in Korea: a case series.
Ryu SW et al.
Cardiovascular Diagnosis and Therapy, 2025
41509624 (PubMed )
Supplement: cdt-15-06-1174-supplementary.pdf
Genetic architecture of hypertrophic cardiomyopathy in individuals of Chinese and United Kingdom ancestry.
Wang J et al.
Precision Clinical Medicine, 2025
40860236 (PubMed )
Supplement: pbaf019_supplemental_files.zip › Supplemental_Tables.pdf
Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies.
Lipov A et al.
Nature Cardiovascular Research, 2023
38666070 (PubMed )
Supplement: 44161_2023_346_MOESM3_ESM.xlsx › S5
Clinical characteristics and survival of children with hypertrophic cardiomyopathy in China: A multicentre retrospective cohort study.
Chan W et al.
Eclinicalmedicine, 2022
35747179 (PubMed )
Supplement: mmc1.pdf
Hemorrhagic stroke caused by moyamoya disease in a patient with obstructive hypertrophic cardiomyopathy.
Liu S et al.
Chinese Medical Journal, 2021
Disease mutations in striated muscle myosins.
Parker F et al.
Biophysical Reviews, 2020
32651905 (PubMed )
Supplement: 12551_2020_721_MOESM1_ESM.pdf
Genetic analysis of monoallelic double MYH7 mutations responsible for familial hypertrophic cardiomyopathy.
Wang B et al.
Molecular Medicine Reports, 2019
The Increasing Importance of Gene-Based Analyses.
Cirulli ET
Plos Genetics, 2016
27055023 (PubMed )
Supplement: pgen.1005852.s006.xlsx › 745papers
Exome sequencing identifies a novel MYH7 p.G407C mutation responsible for familial hypertrophic cardiomyopathy.
Guo Q et al.
Dna and Cell Biology, 2014
Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy.
Melacini P et al.
International Journal of Cardiology, 2008
Select a paper to view details